Clin Mol Hepatol.
2024 Jul;30(3):580-581. 10.3350/cmh.2024.0301.
Functional cure of chronic hepatitis B encounters resmetirom
- Affiliations
-
- 1Department of Hepatology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China
- 2Ningbo Key Laboratory of Translational Medicine Research on Gastroenterology and Hepatology, Ningbo, Zhejiang, China
- 3Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong, China
- 4Department of Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangzhou, China
- 5State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, China
- 6MAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
- 7Key Laboratory of Diagnosis and Treatment for The Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, Zhejiang, China
- KMID: 2557403
- DOI: http://doi.org/10.3350/cmh.2024.0301
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Core protein inhibitors: Opportunities and challenges at the forefront of hepatitis B cure: Editorial on “Phase 1 trial of the safety, pharmacokinetics, and antiviral activity of EDP-514 in untreated viremic chronic hepatitis B patients”
- Quantitative Hepatitis B Surface Antigen, the Trustworthy Biomarker for Functional Cure of Chronic Hepatitis B
- Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus
- 2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C
- New Potential Therapies for Chronic Hepatitis B
